Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eithan Galun

Showing results (91-100 of 160) with videos related to

Pageof 16
Sort By:
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 8, 2006
The use of the hydrodynamic HBV animal model to study HBV biology and anti-viral therapyMali Ketzinel-Gilad, Arie Zauberman, Ofer Nussbaum, et al.
Molecular Cancer Therapeutics|February 8, 2014
Combination of imatinib with CXCR4 antagonist BKT140 overcomes the protective effect of stroma and targets CML in vitro and in vivoKatia Beider, Merav Darash-Yahana, Orly Blaier, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 24, 2010
Neonatal gene therapy of glycogen storage disease type Ia using a feline immunodeficiency virus-based vectorAlbert Grinshpun, Reba Condiotti, Simon N Waddington, et al.
Plos One|November 19, 2008
MicroRNA expression patterns and function in endodermal differentiation of human embryonic stem cellsGalit Tzur, Asaf Levy, Eti Meiri, et al.
European Radiology Experimental|April 2, 2026
Hepatic radiofrequency ablation induces widespread cellular activation throughout the liverMatthias Stechele, Justin Amadi, Lukas Salvermoser, et al.
Hepatology (Baltimore, Md.)|June 16, 2016
The liver-specific microRNA-122*, the complementary strand of microRNA-122, acts as a tumor suppressor by modulating the p53/mouse double minute 2 homolog circuitryAlina Simerzin, Elina Zorde-Khvalevsky, Mila Rivkin, et al.
Molecular Carcinogenesis|January 29, 2002
Analysis of differentially expressed genes in hepatocellular carcinoma using cDNA arraysDaniel Goldenberg, Suhail Ayesh, Tamar Schneider, et al.
European Journal of Immunology|April 29, 2004
Differential usage of VLA-4 and CXCR4 by CD3+CD56+ NKT cells and CD56+CD16+ NK cells regulates their interaction with endothelial cellsSuzanna Franitza, Valentin Grabovsky, Ori Wald, et al.
Plos One|July 9, 2015
Systemic siRNA Nanoparticle-Based Drugs Combined with Radiofrequency Ablation for Cancer TherapyMuneeb Ahmed, Gaurav Kumar, Gemma Navarro, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 26, 2006
Monoclonal antibody HCV-AbXTL68 in patients undergoing liver transplantation for HCV: results of a phase 2 randomized studyThomas D Schiano, Michael Charlton, Zobair Younossi, et al.
Pageof 16

Showing results (91-100 of 160) with videos related to

Sort By:
Pageof 16
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 8, 2006
The use of the hydrodynamic HBV animal model to study HBV biology and anti-viral therapyMali Ketzinel-Gilad, Arie Zauberman, Ofer Nussbaum, et al.
Molecular Cancer Therapeutics|February 8, 2014
Combination of imatinib with CXCR4 antagonist BKT140 overcomes the protective effect of stroma and targets CML in vitro and in vivoKatia Beider, Merav Darash-Yahana, Orly Blaier, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 24, 2010
Neonatal gene therapy of glycogen storage disease type Ia using a feline immunodeficiency virus-based vectorAlbert Grinshpun, Reba Condiotti, Simon N Waddington, et al.
Plos One|November 19, 2008
MicroRNA expression patterns and function in endodermal differentiation of human embryonic stem cellsGalit Tzur, Asaf Levy, Eti Meiri, et al.
European Radiology Experimental|April 2, 2026
Hepatic radiofrequency ablation induces widespread cellular activation throughout the liverMatthias Stechele, Justin Amadi, Lukas Salvermoser, et al.
Hepatology (Baltimore, Md.)|June 16, 2016
The liver-specific microRNA-122*, the complementary strand of microRNA-122, acts as a tumor suppressor by modulating the p53/mouse double minute 2 homolog circuitryAlina Simerzin, Elina Zorde-Khvalevsky, Mila Rivkin, et al.
Molecular Carcinogenesis|January 29, 2002
Analysis of differentially expressed genes in hepatocellular carcinoma using cDNA arraysDaniel Goldenberg, Suhail Ayesh, Tamar Schneider, et al.
European Journal of Immunology|April 29, 2004
Differential usage of VLA-4 and CXCR4 by CD3+CD56+ NKT cells and CD56+CD16+ NK cells regulates their interaction with endothelial cellsSuzanna Franitza, Valentin Grabovsky, Ori Wald, et al.
Plos One|July 9, 2015
Systemic siRNA Nanoparticle-Based Drugs Combined with Radiofrequency Ablation for Cancer TherapyMuneeb Ahmed, Gaurav Kumar, Gemma Navarro, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 26, 2006
Monoclonal antibody HCV-AbXTL68 in patients undergoing liver transplantation for HCV: results of a phase 2 randomized studyThomas D Schiano, Michael Charlton, Zobair Younossi, et al.
Pageof 16